Yandaki QR kodu cep telefonunuzun kamerasını açarak okutun.
​​​​​​​Açılan ekranda ikona tıklayarak AR uygulamasının kameranızı kullanmasına izin verin.

REFERANSLAR: 1. Cohen SB ve ark., A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy. Arthritis Res Ther. 2018;20:155. 2. Pfizer Data on file. Certification of Pfizer Biosimilar Claims 2016. 3. EMA. Genotropin. https://www.ema.europa.eu/en/documents/referral/questions-answers-genotropin-associated-names-somatropin-injection_en.pdf (Erisim tarihi 14.07.2020). 4. EMA. Nivestim. https://www.ema.europa.eu/en/documents/smop-initial/chmp-positive-summary-opinion-nivestim_en.pdf (Erisim tarihi 14.07.2020) 5. Pfizer. Safety of medicines. https://www.pfizer.co.uk/safety-medicines. (Erişim tarihi: 08.09.2021) 6. Pfizer Technology and Manufacturing. https://www.pfizerbiosimil¬ars.com/technology-¬and-m¬anuf¬acturing-biosimil¬ars (Erişim t¬arihi 22.07.2020). 7. Pfizer Pipeline Update 2021. https://cdn.pfizer.com/pfizercom/product-pipeline/Pipeline_Update_28JUL2021.pdf?TZiXMCEFX8hWerkJifoiwer36xxp9l2D (Erişim tarihi 07.09.2021). 8. Data on file Pfizer. 9. Enbrel Kısa Ürün Bilgisi 10. Xeljanz Kısa Ürün Bilgisi 11. Salazopyrin Kısa Ürün Bilgisi 12. İxifi Kısa Ürün Bilgisi 13. Deltacotril Kısa Ürün Bilgisi 14. Smolen JS, Emery P. Infliximab: 12 years of experience. Arthritis Research & Therapy 2011, 13(Suppl 1):S2. 15. Pfizer Data on file. Certification of Pfizer Biosimilar Claims 2016.